Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | HTR2A | P28223 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 2/20 | 0.45 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.45 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.45 |
| ▸ | TACR2 | P21452 | 2/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | SHBG | P04278 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20178575 | 0.92 | HTR2A (0.57) | HTR2AALDH1A1HSD17B10ESR1ADRA2A | |
| SCHEMBL8097075 | 0.86 | LPL (0.45) | CA2HTR2APLK1LPLLIPG | |
| SCHEMBL2494565 | 0.82 | CA2 (0.52) | CA2CA1HTR2AALDH1A1HSD17B10 | |
| SCHEMBL83869 | 0.81 | CA2 (0.65) | CA2CA1HTR2AALDH1A1HSD17B10 | |
| SCHEMBL8090819 | 0.80 | UCHL3 (0.56) | CA2CA1HTR2AALDH1A1HSD17B10 | |
| SCHEMBL9621454 | 0.80 | CA2 (0.50) | CA2CA1HTR2AALDH1A1HSD17B10 | |
| SCHEMBL4055722 | 0.80 | CA2 (0.55) | CA2CA1HTR2AALDH1A1HSD17B10 | |
| SCHEMBL11432616 | 0.78 | CA2 (0.48) | CA2CA1HTR2AALDH1A1HSD17B10 | |
| SCHEMBL8089660 | 0.78 | ALDH1A1 (0.52) | CA2CA1HTR2AALDH1A1HSD17B10 | |
| SCHEMBL28449485 | 0.78 | HTR2A (0.56) | CA2CA1HTR2AALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200392161-A1 | SHP2 PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF | SCHRÖDINGER, INC. | 2020-12-17 | — | — | US | disclosed |
| US-20200062760-A1 | SHP2 PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF | RELAY THERAPEUTICS, INC. | 2020-02-27 | — | — | US | disclosed |
| US-9475756-B2 | Difluoromethylation of aryl and vinyl iodides | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-10-25 | — | — | US | disclosed |
| US-9475756-B2 | Difluoromethylation of aryl and vinyl iodides | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-10-25 | — | — | US | disclosed |
| US-9475756-B2 | Difluoromethylation of aryl and vinyl iodides | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-10-25 | — | — | US | disclosed |
| US-20150045580-A1 | DIFLUOROMETHYLATION OF ARYL AND VINYL IODIDES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-02-12 | — | — | US | disclosed |
| US-20150045580-A1 | DIFLUOROMETHYLATION OF ARYL AND VINYL IODIDES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-02-12 | — | — | US | disclosed |
| US-20150045580-A1 | DIFLUOROMETHYLATION OF ARYL AND VINYL IODIDES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-02-12 | — | — | US | disclosed |
| WO-2013134296-A1 | DIFLUOROMETHYLATION OF ARYL AND VINYL IODIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-09-12 | — | — | WO | disclosed |
| EP-1053990-A2 | A method of producing an aromatic ketone and an aromatic ketone composition containing it | TORAY INDUSTRIES, INC. (JP) | 2000-11-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200062760-A1 | SHP2 PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF | PTPRCAP, PTPRJ, PTPRC | CA2 638/4885CA1 1170/4885HTR2A 3586/4885 |
| US-20200392161-A1 | SHP2 PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF | PTPRCAP, PTPRJ, PTPRC | CA2 1807/4885CA1 3593/4885HTR2A 4287/4885 |
| US-20150045580-A1 | DIFLUOROMETHYLATION OF ARYL AND VINYL IODIDES | CUL2, CUL3, CYP4F2 | CA2 3435/4885CA1 3188/4885HTR2A 3815/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.